Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Jun;23(6):1096-1104.
doi: 10.1007/s12094-020-02497-2. Epub 2020 Sep 18.

Distribution of segmental chromosomal alterations in neuroblastoma

Affiliations
Multicenter Study

Distribution of segmental chromosomal alterations in neuroblastoma

A Juan Ribelles et al. Clin Transl Oncol. 2021 Jun.

Abstract

Background: Neuroblastoma (NB) is a heterogeneous tumor with extremely diverse prognosis according to clinical and genetic factors such as specific combinations of chromosomal imbalances.

Methods: Molecular karyotyping data from a national neuroblastic tumor database of 155 NB samples were analyzed and related to clinical data.

Results: Segmental chromosomal alterations (SCA) were detected in 102 NB, whereas 45 only displayed numerical alterations. Incidence of SCA was higher in stage M (92%) and MYCN amplified (MNA) NB (96%). Presence of SCA was associated with older age, especially 1q gain and 3p deletion. 96% of the deaths were observed in the SCA group and 85% of the relapsed NB contained SCA. The alteration most commonly associated with a higher number of other segmental rearrangements was 11q deletion, followed by 4p deletion. Whole-chromosome 19 gain was associated with lower stages, absence of SCA and better outcome.

Conclusions: SCA are not randomly distributed and are concentrated on recurrent chromosomes. The most frequently affected chromosomes identify prognostic factors in specific risk groups. SCA are associated with older age and MNA. We have identified a small subset of patients with better outcome that share whole-chromosome 19 numeric gain, suggesting its use as a prognostic biomarker in NB.

Keywords: 11q deletion; MYCN amplification; Molecular karyotyping; Segmental chromosomal alterations; Whole gain chromosome 19.

PubMed Disclaimer

References

    1. Mlakar V, Jurkovic Mlakar S, Lopez G, Maris JM, Ansari M, Gumy-Pause F. 11q-del in NB: a review of biological and clinical implications. Mol Cancer. 2017;16(1):114. - DOI
    1. Colon NC, Chung DH. Neuroblastoma. Adv Pediatr. 2011;58(1):297–311. https://doi.org/10.1016/j.yapd.2011.03.011 . - DOI - PubMed - PMC
    1. Schleiermacher G, Janoueix-Lerosey I, Ribeiro A, Klijanienko J, Couturier J, Pierron G, et al. Accumulation of segmental alterations determines progression in neuroblastoma. J Clin Oncol. 2010;28(19):3122–30. - DOI
    1. Defferrari R, Mazzocco K, Ambros IM, Ambros PF, Bedwell C, Beiske K, et al. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localized peripheral neuroblastic tumors without MYCN amplification. Br J Cancer. 2015;112:290–5. - DOI
    1. European Low and Intermediate Risk Neuroblastoma Protocol (LINES 2009). ClinicalTrials.gov Identifier: NCT01728155.

Publication types

LinkOut - more resources